Topical application of Periplaneta americana-derived Meilian Fuxin Solution for head and neck neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Jan 2026: Trial registered, NCT07353671
  2. 1 Mar 2026: Trial started, NCT07353671

The trials

NCT07353671: Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis

State
Under way
Phase
Phase 2 and Phase 3
People
60 planned
Started
1 Mar 2026
Primary completion
31 Dec 2026
Arms
Meilian Fuxin Solution
Results
None posted
  1. 20 Jan 2026: Trial registered
  2. 1 Mar 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.